The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for many.

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

LifeMD expands access to Wegovy and Ozempic at the lowest cash-pay pricing, reinforcing its commitment to patient affordability and high-quality careNEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, ...

Novo Nordisk offers Wegovy and Ozempic at $199/month for new self-pay patients, valid for the first two months until March 31, 2026. The promotion aligns with a national agreement to improve access ...

One of largest U.S. telehealth providers expects to ride wave of exploding demand for weight-loss drug semaglutide when it ...

WHO issues 1st guideline on GLP-1s recommending long-term use with behavioral therapy and notes pricing changes from major manufacturers.

After a photo and video of former first lady went viral on social media speculation about Michelle Obama using a weight loss ...